Catalio Capital Management, LP has filed its 13F form on May 15, 2025 for Q1 2025 where it was disclosed a total value porftolio of $411 Billion distributed in 37 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Becton Dickinson & CO with a value of $46.7B, Spring Works Therapeutics, Inc. with a value of $33.5B, Bridge Bio Pharma, Inc. with a value of $33.3B, Edwards Lifesciences Corp with a value of $31.6B, and Ascendis Pharma A/S with a value of $30.5B.
Examining the 13F form we can see an decrease of $46B in the current position value, from $457B to 411B.
Catalio Capital Management, LP is based out at New York, NY
Below you can find more details about Catalio Capital Management, LP portfolio as well as his latest detailed transactions.
